Почетна › Sitnoćelijski rak pluća › Њујорк › New York City
Kliničke studije za Sitnoćelijski rak pluća u gradu New York City, NY
23 studija za Sitnoćelijski rak pluća traži učesnike na lokacijama u gradu New York City i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.
Zvanični tekst studije (na engleskom)
Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
A Study of Armored CAR T Cells in People With Cancer
Тражи се учесникФаза 1
- Memorial Sloan Kettering Cancer Center (All protocol activities), New York
A Study to Test Obrixtamig in Combination With Pumitamig in People With Advanced Small Cell Lung Cancer (Dareon®-Rosetta35)
Тражи се учесникФаза 1/2
- New York University Langone Medical Center, New York
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
Тражи се учесникФаза 1/2
- Weill Cornell Medicine, Cornell University (site 126), New York
A Study of Valemetostat in Combination With Atezolizumab in People With Lung Cancer
Тражи се учесникФаза 1
- Memorial Sloan Kettering Cancer Center, New York
PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56
Тражи се учесникФаза 1/2
- Memorial Sloan Kettering Cancer Center, New York
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
Тражи се учесникФаза 1/2
- Research Site 107, New York
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
Тражи се учесникФаза 1/2
- Avenzo Therapeutics Recruiting Site, New York
A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1)
Тражи се учесникФаза 1
- NYU Langone Health, New York
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
Тражи се учесникФаза 3
- Cornell University - NewYork-Presbyterian/Weill Cornell Medical Center, New York
A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
Тражи се учесникФаза 1/2
- Clinical Trial Site, New York
A Study of Hospital-at-Home for People Receiving Tarlatamab
Тражи се учесник
- Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York
Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer
Тражи се учесникФаза 2
- Memorial Sloan Kettering Cancer Center - David H. Koch Center for Cancer Care (74th Street)., New York
- Memorial Sloan Kettering Cancer Center, New York
AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors
Тражи се учесникФаза 1
- Memorial Sloan Kettering Cancer Center, New York
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Тражи се учесникФаза 1/2
- Columbia University Medical Center, New York
- Memorial Sloan Kettering, New York
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Тражи се учесникФаза 1
- Memorial Sloan Kettering Cancer Center Head Neck Services, New York
Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors
Тражи се учесникФаза 1/2
- Memorial Sloan Kettering, New York
A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer
Тражи се учесникФаза 1/2
- Memorial Sloan Kettering Cancer Center (MSKCC), New York
- Icahn School of Medicine at Mount Sinai PRIME, New York
Study of Tarlatamab + ZL-1310 +/- Anti-programmed Death Ligand 1 (Anti-PD-L1) in Small Cell Lung Cancer (SCLC)
Тражи се учесникФаза 1
- New York University Cancer Institute, New York
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
Тражи се учесникФаза 3
- Laura and Isaac Perlmutter Cancer Center at NYU Langone Health Long Island, New York
- New York University Cancer Center - Laura and Isaac, New York
A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer
Тражи се учесникФаза 1/2
- Columbia University Medical Center - Herbert Irving Pavilion, New York
A Study of Stereotactic Radiosurgery (SRS) for People With Lung Cancer That Has Spread to the Brain
Тражи се учесникФаза 2
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Lung Cancer Biomarkers and Screening
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
- NYU Cancer Institute at New York University Medical Center, New York
Genomic and Methylation Markers in SCLC and LCNEC for Chemo-Immunotherapy Resistance Prediction (STRATUS)
Тражи се учесникОпсервациона студија
- Icahn School of Medicine at Mount Sinai, New York
Studije za Sitnoćelijski rak pluća u drugim gradovima
- Houston, TX26 студија
- Arlington, VA22 студија
- Boston, MA22 студија
- Los Angeles, CA20 студија
- Nashville, TN20 студија
- Orlando, FL14 студија
- Chicago, IL13 студија
- Cleveland, OH13 студија
- Dallas, TX13 студија
- St. Louis, MO13 студија
- Washington, DC13 студија
- Detroit, MI12 студија
Ostale studije u gradu New York City
- Рак дојке144 студија
- Немалоклетни карцином плућа123 студија
- Рак (све врсте)105 студија
- Рак простате101 студија
- Метастатски карцином93 студија
- Колоректални карцином86 студија
- Рак јајника75 студија
- Рак плућа60 студија
- Многи мијелом59 студија
- Рак панкреаса57 студија
- Карцином ендометријума54 студија
- Akutna mijeloidna leukemija51 студија
Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.